MATEON’S GLOBAL STUDY FOR OT-101/ TGF-β INHIBITOR AGAINST COVID-19 ENROLLS AND TREATS ITS FIRST PATIENT

by NASDAQ Market News December 30, 2020

NASDAQ Market News
Click here to email author

Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen

Skylight Health Announces Closing of Tennessee Clinic with $2.2 Million in Revenue and Positive EBITDA

Ads